Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 4 , ISSUE 4 ( October-December, 2020 ) > List of Articles

REVIEW ARTICLE

Clinical Safety of Selected Ayurvedic Formulations in Osteoarthritis

Sunita, Shruti Khanduri, Sarada Ota, Pradeep Dua, Babita Yadav, Savita Sharma, Hemant Panigrahi, Puthanveetil Kesavan Sudarsanan Nair, Tapsi Borah, Deepa Makhija, Radhakrishnan, Dinesh Baruah, Anil Mangal, Uday Ravi Sekhar Namburi, Maha Meda Rao, Veliparambil Chandran Deep, Pramila Devi, Shubhashree Thejasvi, D Ankush, Ankush Jadhav, AJV Sai Prasad, Vinod K Lavaniya, V Rakesh Narayanan, Rakesh Rana, Richa Singhal, Bharti Gupta, Madan Mohan Padhi, Narayanam Srikanth

Citation Information : S, Khanduri S, Ota S, Dua P, Yadav B, Sharma S, Panigrahi H, Nair PK, Borah T, Makhija D, R, Baruah D, Mangal A, Namburi UR, Rao MM, Deep VC, Devi P, Thejasvi S, Ankush D, Jadhav A, Prasad AS, Lavaniya VK, Narayanan VR, Rana R, Singhal R, Gupta B, Padhi MM, Srikanth N. Clinical Safety of Selected Ayurvedic Formulations in Osteoarthritis. J Res Ayurvedic Sci 2020; 4 (4):139-148.

DOI: 10.5005/jras-10064-0118

License: CC BY-NC 4.0

Published Online: 01-12-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Abstract

Background: Osteoarthritis (OA) is one of the most common forms of arthritis which is caused by the degeneration of joint cartilage. It is often associated with disability and leads to impairment of quality of life. The clinical picture is similar to the disease Sandhigatavata described in Ayurveda (one among the Vatavyadhi) and is characterized by symptoms such as Sandhi Shoola (joint pain), Sandhishopha (swelling of joint), and Prasarana-Akunchana-Ashakti (difficulty in movements of the joint). The safety of 10 Ayurvedic classical formulations most commonly used in OA was clinically evaluated and the findings are provided in this article. Aim and objective: Critical analysis of clinical safety outcomes of classical Ayurvedic formulations, viz. Vatari Guggulu, Yogaraj Guggulu, Punarnava Guggulu, Maharasnadi Kwatha, Dashmoola Ghrita, Narayan Taila, Kottamchukkadi Taila, Gandharvahasta Taila, Dhanwantara Taila, and Ksheerbala Taila in patients of OA, generated through studies at different Institutes of Central Council for Research in Ayurvedic Sciences (CCRAS). Materials and methods: Data collected from four different clinical studies completed in multiple centers of CCRAS were retrospectively evaluated to assess the safety profile of 10 formulations that are commonly used in OA. Evaluation of safety was done by analyzing liver function tests (LFT) and renal function tests (RFT) before and after the trial period. Paired sample t-test was used to compare mean change from baseline to the 84th day. A p value of <0.05 was considered significant. Conclusion: The findings in four different clinical studies reveal that all ten formulations are clinically safe in patients belonging to various age groups, gender, geographical area, and Prakriti.


PDF Share
  1. Vrdoljak D, Selimovic M, Marin A, et al. Celecoxib for osteoarthritis. In: Cochrane Database of Systematic Reviews Puljak L, ed., Chichester, UK: John Wiley & Sons##Ltd 2012.
  2. Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian. J Intern Med Suppl 2011;2(2):205–212.
  3. World Health Organization, 19th WHO Model List of Essential Medicines. http://www.who.int/Medicines/Publications/Essentialmedicines/En. 2015 April: 1–43.
  4. Pal C, Singh P, Chaturvedi S, et al. Epidemiology of knee osteoarthritis in India and related factors. Indian J Orthop 2016;50(5):518.
  5. Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex process that involves the entire joint. J Med Life 2014;7(1):37–41.
  6. Walker-Bone K, Javaid K, Arden N, et al. Medical management of osteoarthritis. BMJ: Br Med J 2000;321(7266):936–940.
  7. Witt CM, Michalsen A, Roll S, et al. Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee-study protocol for a randomized controlled trial. Trials 2013;14:149.
  8. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. II 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2008. p. 136.
  9. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. II 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2008. p. 141.
  10. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. II 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2008. p. 124.
  11. Shastri A, ed. Bhaishajyaratnavali of Govindadasa, ch 29, Ver. 28-35 6th ed., Varanasi: Chaukhambha Sanskrit Sansthan;; 1981. p. 436.
  12. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. I 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2007. p. 65.
  13. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. III 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2010. p. 84.
  14. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. I 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2007. p. 122.
  15. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. I 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2007. p. 120.
  16. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. I 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2007. p. 117.
  17. Anonymous. Ayurvedic Pharmacopoiea of India, Part - II vol. I 1st ed., New Delhi: The Controller of Publications, Govt. of India; 2007. p. 124.
PDF Share
PDF Share